Active Monitoring of Oxytocin Research Evidence
  • Living Meta-Analysis
  • Contact
  • Guidelines
  • Standardized framework
  • Resources
  • About
  • Home

About AMORE

Advancing Oxytocin Research Together

Building the future of evidence-based research through living meta-analysis and transparent science

What is AMORE?

AMORE (Active Monitoring of Oxytocin Research Evidence) is a platform that hosts living meta-analyses for oxytocin research investigating biobehavioral outcomes in humans. Each living meta-analysis on AMORE is regularly updated to incorporate new research as it is published, ensuring that the evidence synthesis remains current. All projects on AMORE follow a standardized framework that upholds methodological rigor and transparency.

Aims of AMORE

AMORE provides researchers with access to the most current meta-analytic evidence in oxytocin biobehavioral research. New studies are integrated into the living meta-analyses over time. The update approach is determined by each research team -- some projects update continuously as new studies meeting inclusion criteria are published, others update at set intervals (e.g. every 6, 12, or 24 months), and others update when new evidence is expected to meaningfully change the conclusions. Regardless of the approach, all projects must update within a maximum of 24 months.

The expert steering committee reviews all project proposals to ensure they meet the requirements of the AMORE standardized framework. The committee also monitors ongoing projects to ensure continued adherence to the framework throughout the lifetime of each living meta-analysis.

The AMORE standardized framework requires open science practices for all projects. This includes pre-registration of protocols, use of free and open-source analysis software, public sharing of datasets and analysis scripts, deviation reports documenting any departures from the registered protocol, and publication of pre-prints. These requirements ensure that every step of the research process is transparent and reproducible.

Who Is AMORE For?

Research Teams Researchers or research teams who want to publish and maintain a living meta-analysis on oxytocin research investigating biobehavioral outcomes in humans.
Anyone Interested in Oxytocin Research Anyone who wants to explore up-to-date meta-analytic evidence on oxytocin and biobehavioral outcomes in humans, whether for academic, educational, or general interest.
Clinicians Clinicians seeking reliable, continuously updated evidence syntheses of human oxytocin research to inform clinical practice and decision-making.

What Are Living Meta-Analyses?

A living meta-analysis is a meta-analysis that is updated over time with a clear, pre-defined intention to incorporate new evidence as it becomes available. Unlike a traditional meta-analysis, which represents a snapshot of the evidence at a single point in time and quickly becomes outdated, a living meta-analysis is designed to remain current.

How Do They Differ from Traditional Meta-Analyses?

A traditional meta-analysis searches the literature up to a fixed date, synthesizes the available evidence, and is published as a final product. As new studies are published after that date, the conclusions may no longer reflect the full body of evidence. A living meta-analysis addresses this by committing to regular updates – ensuring that the synthesis evolves alongside the growing literature.

It is important to note that “living meta-analysis” does not refer to a specific statistical method or analytical technique. Rather, it describes an approach where any form of meta-analytic methodology can be applied, with the distinguishing feature being the ongoing commitment to updating the analysis over time.

Traditional vs. Living Meta-Analysis comparison

Figure: Traditional vs. Living Meta-Analysis

Update Strategies

Different living meta-analysis projects may adopt different update strategies depending on the research question and the rate at which new studies are published:

  • Continuous updates: Some projects update every time a new study meeting the inclusion criteria is published. This approach provides the most current evidence at all times but requires ongoing monitoring of the literature.
  • Threshold-based updates: Other projects update when new evidence is expected to meaningfully alter the conclusions – for example, when a sufficiently large or methodologically important study is published.
  • Fixed-interval updates: Some projects update on a set schedule (e.g. every 6, 12, or 24 months), regardless of how many new studies have appeared. This approach is more predictable and easier to plan around.

On AMORE, all projects must update within a maximum of 24 months. The specific update strategy is determined by the research team and documented in their pre-registered protocol.

Methodological Considerations

When a living meta-analysis is updated multiple times, the repeated testing of the same hypothesis with accumulating data raises statistical considerations. Corrections for multiple rounds of analysis may be necessary to control the overall error rate. Researchers should pre-specify their approach to handling this in their registered protocol.

Maintaining Evidence Integrity

A key advantage of the living approach is the ability to respond to changes in the literature. When papers included in the analysis are retracted or corrected, the living meta-analysis can be updated to reflect this – removing retracted studies and re-running the analysis. This ensures that the evidence synthesis is based only on reliable, non-retracted research.

Expert Steering Committee

The AMORE platform is overseen by a steering committee of experts in the oxytocin research field. The committee:

  • Approves project proposals
  • Provides methodological guidance
  • Ensures computational reproducibility
  • Maintains platform standards

Committee Members

Prof. Daniel S. Quintana Department of Psychology, University of Oslo, Oslo, Norway
KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway
NevSom, Department of Rare Disorders, Oslo University Hospital, Oslo, Norway

Prof. Marian Bakermans-Kranenburg William James Center for Research, ISPA – University Institute of Psychological, Social and Life Sciences, Lisbon, Portugal

Prof. Jessica J. Connelly Department of Psychology, Program in Fundamental Neuroscience, University of Virginia, Charlottesville, USA

MPhil Heemin Kang Department of Psychology, University of Oslo, Oslo, Norway

Prof. Jennifer A. Bartz Department of Psychology, McGill University, Montréal, Québec, Canada

Prof. Natalie C. Ebner Department of Psychology, University of Florida, Gainesville, FL, USA
Cognitive Aging and Memory Center, McKnight Brain Institute, University of Florida, Gainesville, FL, USA

Prof. Dirk Scheele Department of Social Neuroscience, Faculty of Medicine, Ruhr University Bochum, Germany
Research Center One Health Ruhr of the University Alliance Ruhr, Ruhr University Bochum, Germany

Prof. Benjamin Becker State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong, China
Department of Psychology, The University of Hong Kong, Hong Kong, China

Prof. Kaat Alaerts Department of Rehabilitation Sciences, KU Leuven, Neuromotor Rehabilitation Research

Dr. Matthijs Moerkerke Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium

Dr. Elizabeth A. Lawson Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Massachusetts, USA
Department of Medicine, Harvard Medical School, Boston, USA

Dr. Tanya L. Procyshyn Department of Biological Sciences, Simon Fraser University, Burnaby, Canada
Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK

Dr. Marilyn Horta Department of Health Outcomes and Behavior, Moffitt Cancer Center, Florida, USA

Prof. Hidenori Yamasue Departments of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu City, Japan

Constantina Theofanopoulou The Rockefeller University, New York, NY, USA
New York University, New York, NY, USA
Emory University, Atlanta, GA, USA

Dr. Leehe Peeled Avron Department of Psychology, Bar-Ilan University, Ramat-Gan, Israel

Senior Scientist Nicole Nadine Løndtfelt Center for Social Data Science, Faculty of Social Sciences, University of Copenhagen
Child and Adolescent Mental Health Center, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark

Dr. Ekaterina Schneider Institute of Medical Psychology, Center for Psychosocial Medicine, Heidelberg University Hospital, Heidelberg, Germany

Prof. Beate Ditzen Institute of Medical Psychology, Center for Psychosocial Medicine, Heidelberg University Hospital, Heidelberg, Germany

Anna-Rosa Cecilie Mora-Jensen Child and Adolescent Mental Health Center, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen

Prof. Christian Montag Centre for Cognitive and Brain Sciences, Institute of Collaborative Innovation, University of Macau, Macau SAR, China
Department of Psychology, Faculty of Social Sciences, University of Macau, Macau SAR, China
Department of Computer and Information Science, Faculty of Science and Technology, University of Macau, Macau SAR, China

Prof. Robert James Blair Department of Clinical Medicine, Child and Adolescent Psychiatry, University of Copenhagen, Copenhagen, Denmark

MSc Alina I. Sartorious Department of Psychology, University of Oslo, Oslo, Norway

MSc Ingebjørg Anjadatter Iversen Department of Psychology, University of Oslo, Oslo, Norway

How to Cite AMORE

Please use the following reference to cite AMORE:

Iversen, I. A., Alaerts, K., Bakermans-Kranenburg, M., Becker, B., Blair, R. J., Bartz, J. A., Connelly, J. J., Ditzen, B., Ebner, N. C., Kang, H., Lawson, E. A., Lønfeldt, N. N., Moerkerke, M., Montag, C., Mora-Jensen, A.-R. C., Horta, M., Peled-Avron, L., Procyshyn, T. L., Sartorius, A. I., … Quintana, D. S. (2025). The active monitoring of oxytocin research evidence (AMORE) platform. Psychoneuroendocrinology, 107713. https://doi.org/10.1016/j.psyneuen.2025.107713

 
  • Behavioral Neuroendocrinology Lab